RNAC Competitors & Alternatives
Compare Cartesian Therapeutics Inc. with similar stocks in the same industry
Biotechnology
RNAC
Main Stock$8.65
Tradestie Score
57
Market Cap
$266.26M
Revenue Growth
-0.9%
Analyst Upside
+311.2%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OMER
Omeros Corporation
|
$14.13
|
$281.75M | - | 61 | Compare |
|
DBVT
DBV Technologies S.A.
|
$19.73
|
$275.54M | - | 50 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.28
|
$275.13M | - | 50 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$16.94
|
$269.08M | - | 53 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$9.35
|
$258.18M | - | 50 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$30.78
|
$256.54M | - | 61 | Compare |
|
CABA
Cabaletta Bio, Inc. Common Stock
|
$3.88
|
$211.28M | - | 61 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$5.01
|
$211.22M | - | 59 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.93
|
$202.58M | - | 64 | Compare |
More RNAC Analysis
Data updated: May 09, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry